相关实验视频

Updated: May 1, 2026

Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells

Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells

Published on: March 3, 2015

化学保护性策略确定了pfUCHL3作为Halofuginone的目标

Si-Miao Yu¹, Mei-Mei Zhao¹, Yong-Zhe Zheng¹

¹State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.

Chembiochem : a European journal of chemical biology

|June 26, 2024

概括

哈洛基能有效向Plasmodium falciparum,通过抑制无处不在的碳素终端酶3 (PfUCHL3),这是寄生虫生长和新陈代谢的关键蛋白质,为疟疾药物开发提供了新的途径.

科学领域:

生物化学生化学
寄生虫学的寄生虫学
药物发现药物发现药物发现

背景情况:

疟疾仍然是一个主要的全球健康威胁,由菌菌引起.
黄 (HF) 显示出显著的抗疟疾活性.
识别HF的直接分子标对于开发新疗法至关重要.

研究的目的:

为了识别Plasmodium falciparum中Halofuginone (HF) 的直接标蛋白.
阐明HF抑制寄生虫生长的机制.
探索pfUCHL3作为疟疾的潜在药物标.

主要方法:

对HF进行光亲和标记探针的合成.
使用探针识别HF的直接标蛋白.
对HF与目标蛋白的相互作用及其对寄生虫生物学下游影响的分析.

主要成果:

在P. falciparum.中,乌比奎丁碳素终端酶3 (PfUCHL3) 被确定为HF的直接标.
HF与pfUCHL3结合,诱导全效应并扰乱寄生虫的生长.
在寄生虫中,HF抑制了氨基酸生物合成和代谢所必需的蛋白质的表达.

结论:

PfUCHL3是Halofuginone在疟疾治疗中的新型,可用药物的标.
通过Pfuchl3了解HF的机制为开发新的抗疟疾药物提供了基础.
这项研究为对抗Plasmodium falciparum感染开辟了新的可能性.

关键词:

化学蛋白质组 (chemoproteome) 是一种化学蛋白质组.没有二维基因酸酶.有一种叫做 halofuginone 的成分.疟疾疟疾是一种疾病.摄影亲和度标签的使用方法

更多相关视频

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury

Published on: June 16, 2018

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...